3-MATIDA

CAS No. 518357-51-2

3-MATIDA( 3-MATIDA )

Catalog No. M17529 CAS No. 518357-51-2

3-MATIDA is an effective mGluR-1 antagonist (IC50: 6.3 μM, rat mGluR-1a).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 45 In Stock
5MG 70 In Stock
10MG 114 In Stock
25MG 234 In Stock
50MG 381 In Stock
100MG 565 In Stock
500MG 1215 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-MATIDA
  • Note
    Research use only, not for human use.
  • Brief Description
    3-MATIDA is an effective mGluR-1 antagonist (IC50: 6.3 μM, rat mGluR-1a).
  • Description
    3-MATIDA is an effective mGluR-1 antagonist (IC50: 6.3 μM, rat mGluR-1a). Displays ≥ 40-fold selectivity over other receptors: mGluR-5, mGluR-2, mGluR-4 (mGluR-4a) (IC50 > 300 μM), NMDA and GluR (AMPA) (IC50 = 250 μM). 3-MATIDA act as a neuroprotectant in cultured murine cortical cells and rat hippocampal slice cultures in vitro.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-MATIDA
  • Pathway
    Tyrosine Kinase
  • Target
    Trk Receptor
  • Recptor
    mGluR1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    518357-51-2
  • Formula Weight
    215.22
  • Molecular Formula
    C8H9NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cc1c(sc(c1)C(=O)O)C(C(=O)O)N
  • Chemical Name
    3-Methyl-aminothiophene dicarboxylic acid; 5-(Amino(carboxy)methyl)-4-methylthiophene-2-carboxylic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moroni, F., et al. 2002. Neuropharmacology. 42: 741-751.
molnova catalog
related products
  • CG 428

    CG 428 is a potent tropomyosin receptor Kinase (TRK) Degrader (uSMITETM) with a DC50 of 0.36 nM. CG 428 comprises an analog of the pan-TRK inhibitor GNF-8625 joined by a linker to the cereblon E3 ligase ligand pomalidomide.

  • (3aR)-Selitrectinib

    (6RS)-LOXO-195 is a potent and selective Trk tyrosine kinase inhibitor.

  • Cyclotraxin B

    Antagonist of TrkB receptors; inhibits BDNF-induced TrkB activity (IC50 = 0.30 nM). Allosterically alters TrkB receptor conformation but does not alter BDNF binding. Prevents BDNF-induced cold allodynia in mice. Also shown to exhibit putative anxiolytic properties in mice.